C5AR1 and epilepsy: Overall, the epilepsy literature supports a node-based model in which aberrant C1q/C3 activity remodels synapses and glia, C5aR1 signaling amplifies inflammation and excitability, and terminal-pathway overactivity risks direct cytotoxicity, each providing a mechanistic foothold for therapy.